Centerpoint Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
1,695
+12
| +0.7% | +$2.23K | 0.11% | 68 |
|
|
2025
Q1 | $353K | Buy |
1,683
+3
| +0.2% | +$629 | 0.13% | 62 |
|
|
2024
Q4 | $298K | Sell |
1,680
-138
| -8% | -$24.5K | 0.1% | 71 |
|
|
2024
Q3 | $359K | Sell |
1,818
-96
| -5% | -$19K | 0.12% | 61 |
|
|
2024
Q2 | $328K | Sell |
1,914
-149
| -7% | -$25.5K | 0.12% | 65 |
|
|
2024
Q1 | $376K | Buy |
2,063
+328
| +19% | +$59.8K | 0.14% | 56 |
|
|
2023
Q4 | $269K | Buy |
1,735
+118
| +7% | +$18.3K | 0.11% | 71 |
|
|
2023
Q3 | $241K | Buy |
1,617
+4
| +0.2% | +$596 | 0.1% | 81 |
|
|
2023
Q2 | $217K | Sell |
1,613
-134
| -8% | -$18K | 0.09% | 83 |
|
|
2023
Q1 | $278K | Buy |
1,747
+325
| +23% | +$51.7K | 0.12% | 74 |
|
|
2022
Q4 | $230K | Buy |
1,422
+11
| +0.8% | +$1.78K | 0.11% | 79 |
|
|
2022
Q3 | $189K | Buy |
1,411
+904
| +178% | +$121K | 0.1% | 80 |
|
|
2022
Q2 | $78K | Buy |
507
+113
| +29% | +$17.4K | 0.04% | 122 |
|
|
2022
Q1 | $64K | Buy |
394
+3
| +0.8% | +$487 | 0.03% | 134 |
|
|
2021
Q4 | $53K | Buy |
391
+3
| +0.8% | +$407 | 0.02% | 131 |
|
|
2021
Q3 | $42K | Buy |
388
+43
| +12% | +$4.66K | 0.02% | 134 |
|
|
2021
Q2 | $39K | Buy |
+345
| New | +$39K | 0.02% | 139 |
|
|
2018
Q4 | – | Sell |
-675
| Closed | -$64K | – | 250 |
|
|
2018
Q3 | $64K | Buy |
675
+570
| +543% | +$54K | 0.05% | 87 |
|
|
2018
Q2 | $10K | Buy |
105
+39
| +59% | +$3.71K | 0.01% | 176 |
|
|
2018
Q1 | $6K | Buy |
+66
| New | +$6K | 0.01% | 173 |
|